Value PharmaPain Reliever

Product NDC: 42787-102
11-digit product format: 427870102
Labeler code: 42787
Product ID: 42787-102_893f4de2-d639-4e24-9c95-741b3f90a25e
Type: HUMAN OTC DRUG
Nonproprietary name: Aspirin
Dosage form: TABLET
Route: ORAL
Labeler: Ajes Pharmaceuticals,LLC
Application: part343
Marketing category: OTC MONOGRAPH FINAL
Marketing start: 2012-10-01
Marketing end: 0000-00-00
Substance: ASPIRIN
Active strength: 325 mg/325mg
NDC exclude flag: No
Listing certified through: 2019-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 4 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	42787-102		I	Inactivated by FDA	2026-10-12
excluded product	product	42787-102		I	Inactivated by FDA	2026-10-12
excluded package	package	42787-102	42787-102-50	I	Inactivated by FDA	2026-10-12
excluded package	package	42787-102	42787-102-12	I	Inactivated by FDA	2026-10-12

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 2 · 84 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	42787-102-50	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	42787-102-12	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	42787-102-50	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	42787-102-12	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	42787-102-50	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	42787-102-12	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	42787-102-50	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	42787-102-12	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	42787-102-50	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	42787-102-12	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	42787-102-50	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	42787-102-12	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	42787-102-50	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	42787-102-12	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	42787-102-50	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	42787-102-12	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	42787-102-50	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	42787-102-12	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	42787-102-50	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	42787-102-12	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	42787-102-50	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	42787-102-12	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	42787-102-50	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	42787-102-12	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	42787-102-50	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	42787-102-12	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	42787-102-50	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	42787-102-12	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	42787-102-50	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	42787-102-12	`1332a3947898…`	`d4bfe170f9cd…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
d7724692-1155-4cc8-a415-22f5fc4aec35	Product name	6	20220216
bde672ba-4805-28d0-1986-73543d41b412	Product name	2	20210201
f212291f-05fe-9603-fc7e-bd73e38ce1e6	Product name	2	20161129
ade821ba-260a-47e2-bd89-743e27ac9906	Product name	1	20161121
182f9ab4-4ab5-c449-200f-87ce2ce8e550	Product name	2	20151105
9425d234-4ae1-4b53-adc6-8cc7af6dd657	Product name	1	20150929
2a21311a-89e2-0e83-2ebd-117f9798b2b2	Product name	1	20140508
9007e8a7-ff50-f9b9-7945-f2a1deadd94e	Product name	1	20140508
96c2be53-8e44-452d-56a2-d255b2f1af2d	Product name	1	20140508
bf8bd5f7-495f-4022-2780-7ded7ea7ea44	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
42787-102-12	2020-01-31	C162847	48780-1	9d75b9d0-a8d3-f424-e053-dadaa90a57ce	Drug Facts
42787-102-50	2020-01-31	C162847	48780-1	9d75b9d0-bf3e-f424-e053-dadaa90a57ce	Drug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
42787-102-12	Value PharmaPain RelieverExtra Strength	1 in 1 CARTON	TABLET	1	2
42787-102-12	Value PharmaPain RelieverExtra Strength	325000 mg in 1 BOTTLE	TABLET	325000	2
42787-102-50	Value PharmaPain RelieverExtra Strength	16250 mg in 1 BOTTLE	TABLET	16250	2
42787-102-50	Value PharmaPain RelieverExtra Strength	1 in 1 CARTON	TABLET	1	2

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
Aspirin	ACTIVE INGREDIENT	R16CO5Y76E	VALUE PHARMAPAIN RELIEVER EXTRA STRENGTH (ASPIRIN) TABLET [AJES PHARMACEUTICALS,LLC]	2
Aspirin	ACTIVE INGREDIENT	R16CO5Y76E	VALUE PHARMAPAIN RELIEVER EXTRA STRENGTH (ASPIRIN) TABLET [AJES PHARMACEUTICALS,LLC]	2
Aspirin	ACTIVE MOIETY	R16CO5Y76E	VALUE PHARMAPAIN RELIEVER EXTRA STRENGTH (ASPIRIN) TABLET [AJES PHARMACEUTICALS,LLC]	2
Aspirin	ACTIVE MOIETY	R16CO5Y76E	VALUE PHARMAPAIN RELIEVER EXTRA STRENGTH (ASPIRIN) TABLET [AJES PHARMACEUTICALS,LLC]	2
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	VALUE PHARMAPAIN RELIEVER EXTRA STRENGTH (ASPIRIN) TABLET [AJES PHARMACEUTICALS,LLC]	2
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	VALUE PHARMAPAIN RELIEVER EXTRA STRENGTH (ASPIRIN) TABLET [AJES PHARMACEUTICALS,LLC]	2
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	VALUE PHARMAPAIN RELIEVER EXTRA STRENGTH (ASPIRIN) TABLET [AJES PHARMACEUTICALS,LLC]	2
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	VALUE PHARMAPAIN RELIEVER EXTRA STRENGTH (ASPIRIN) TABLET [AJES PHARMACEUTICALS,LLC]	2
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	VALUE PHARMAPAIN RELIEVER EXTRA STRENGTH (ASPIRIN) TABLET [AJES PHARMACEUTICALS,LLC]	2
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	VALUE PHARMAPAIN RELIEVER EXTRA STRENGTH (ASPIRIN) TABLET [AJES PHARMACEUTICALS,LLC]	2
talc	INACTIVE INGREDIENT	7SEV7J4R1U	VALUE PHARMAPAIN RELIEVER EXTRA STRENGTH (ASPIRIN) TABLET [AJES PHARMACEUTICALS,LLC]	2
talc	INACTIVE INGREDIENT	7SEV7J4R1U	VALUE PHARMAPAIN RELIEVER EXTRA STRENGTH (ASPIRIN) TABLET [AJES PHARMACEUTICALS,LLC]	2
Titanium Dioxide	INACTIVE INGREDIENT	15FIX9V2JP	VALUE PHARMAPAIN RELIEVER EXTRA STRENGTH (ASPIRIN) TABLET [AJES PHARMACEUTICALS,LLC]	2
Titanium Dioxide	INACTIVE INGREDIENT	15FIX9V2JP	VALUE PHARMAPAIN RELIEVER EXTRA STRENGTH (ASPIRIN) TABLET [AJES PHARMACEUTICALS,LLC]	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
42787-102	VALUE PHARMAPAIN RELIEVER EXTRA STRENGTH (ASPIRIN) TABLET [AJES PHARMACEUTICALS,LLC]	2	Legacy NDC, 2 package rows	20121116_ce54315f-02ae-49c4-b42f-79c17a4cc2d7.zip
42787-102	VALUE PHARMAPAIN RELIEVER EXTRA STRENGTH (ASPIRIN) TABLET [AJES PHARMACEUTICALS,LLC]	2	Legacy NDC, 2 package rows	20140526_b4a9f50f-9eda-4d8f-91be-4053ee6ce0ec.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
R16CO5Y76E	ASPIRIN	50-78-2	ASPIRIN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
212033	aspirin 325 MG Oral Tablet	PSN	b4a9f50f-9eda-4d8f-91be-4053ee6ce0ec	2
212033	aspirin 325 MG Oral Tablet	PSN	ce54315f-02ae-49c4-b42f-79c17a4cc2d7	2
212033	aspirin 325 MG Oral Tablet	SCD	b4a9f50f-9eda-4d8f-91be-4053ee6ce0ec	2
212033	aspirin 325 MG Oral Tablet	SCD	ce54315f-02ae-49c4-b42f-79c17a4cc2d7	2
212033	ASA 325 MG Oral Tablet	SY	b4a9f50f-9eda-4d8f-91be-4053ee6ce0ec	2
212033	ASA 325 MG Oral Tablet	SY	ce54315f-02ae-49c4-b42f-79c17a4cc2d7	2

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Status
42787-102-12	42787010212	1 in 1 CARTON		Historical
42787-102-50	42787010250	16250 mg in 1 BOTTLE	16250 mg	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Drug Facts	Ajes Pharmaceuticals,LLC	2014-05-25	HUMAN OTC DRUG LABEL	2
Drug Facts	Ajes Pharmaceuticals,LLC	2012-11-15	HUMAN OTC DRUG LABEL	2